We are live on
!
Find out more
PAM
Premier Asset Management Portfolio holdings
AUM
$79.6M
1-Year Est. Return
10.77%
This Fund
S&P 500
This Quarter
Est. Return
+5.84%
1 Year Est. Return
-10.77%
3 Year Est. Return
+104.47%
5 Year Est. Return
+166.2%
10 Year Est. Return
–
AUM
$446M
AUM Growth
+$12.6M
(+2.9%)
Cap. Flow
-$8.04M
Cap. Flow
% of AUM
-1.8%
Top 10 Holdings %
Top 10 Hldgs %
34.01%
Holding
115
New
10
Increased
26
Reduced
58
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$7.41M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$1.33M |
| 3 |
HBI
Hanesbrands
HBI
|
+$790K |
| 4 |
AT&T
T
|
+$720K |
| 5 |
ExxonMobil
XOM
|
+$635K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$10.1M |
| 2 |
NXP Semiconductors
NXPI
|
+$1.85M |
| 3 |
Novartis
NVS
|
+$1.34M |
| 4 |
TUP
Tupperware Brands Corporation
TUP
|
+$657K |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$574K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.95% |
| 2 | Financials | 17.54% |
| 3 | Industrials | 14.25% |
| 4 | Technology | 12.58% |
| 5 | Consumer Discretionary | 11.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Abbott
ABT
$195B
| $335K | 0.08% |
6,284
+220
| +4% | +$11K |
|
102
Schwab International Equity ETF
SCHF
$69.3B
| $324K | 0.07% |
19,360
+1,350
| +7% | +$22K |
|
103
Bristol-Myers Squibb
BMY
$136B
| $316K | 0.07% |
4,961
| – | – |
|
104
Public Service Enterprise Group
PEG
$36.5B
| $311K | 0.07% |
6,725
+1,369
| +26% | +$62K |
|
|
ITCI
105
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $291K | 0.07% |
+18,429
| New | +$270K |
|
106
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.03B
| $260K | 0.06% |
4,120
| – | – |
|
|
BEAT
107
DELISTED
BioTelemetry, Inc.
BEAT
| $237K | 0.05% |
+7,170
| New | +$248K |
|
108
Gogo Inc
GOGO
$369M
| $232K | 0.05% |
+19,611
| New | +$250K |
|
109
Lockheed Martin
LMT
$130B
| $217K | 0.05% |
+699
| New | +$209K |
|
110
iShares Core S&P Small-Cap ETF
IJR
$110B
| $202K | 0.05% |
2,721
-90
| -3% | -$6.31K |
|
111
MBIA
MBI
$244M
| $95K | 0.02% |
+10,903
| New | +$109K |
|
|
112
Lowe's Companies
LOW
$117B
| – | – |
-129,888
| Closed | -$10.1M |
|
|
113
Novartis
NVS
$292B
| – | – |
-17,901
| Closed | -$1.34M |
|
|
114
Teva Pharmaceuticals
TEVA
$42.5B
| – | – |
-17,300
| Closed | -$574K |
|
Similar funds
S
CFS
CLCM
BO
BC
SGMPI
LCH
SCFS
Premier Asset Management's Q3 2017 Portfolio in Review
As of Q3 2017, Premier Asset Management held 115 positions worth $446M, up 2.9% from $433M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Premier Asset Management's Q3 2017 filing shows 10 new, 26 increased, 58 reduced and 4 closed positions. Its largest new stake was Alexion Pharmaceuticals: 54,540 shares worth $7.65M. The largest sale was Lowe's Companies, an estimated $10.1M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Premier Asset Management's largest Q3 2017 buy was Alexion Pharmaceuticals: 54,540 shares worth $7.65M.
- Premier Asset Management added most to AT&T in Q3 2017, an estimated $720K increase.
- Premier Asset Management's biggest Q3 2017 reduction was NXP Semiconductors, cutting an estimated $1.85M.
- Premier Asset Management fully exited Lowe's Companies in Q3 2017, selling an estimated $10.1M.
- Premier Asset Management's ten largest holdings make up 34% of its $446M portfolio in Q3 2017.
- Premier Asset Management opened 10 new positions and closed 4 in Q3 2017.
- Premier Asset Management's portfolio value rose 2.9% quarter-over-quarter to $446M.
Based on Premier Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.